Patents by Inventor Jaya Abraham
Jaya Abraham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11413239Abstract: The present invention relates to a pharmaceutical composition of tapentadol for nasal administration. Present invention also relates to the process of preparation of pharmaceutical composition of tapentadol for nasal administration and its use in the treatment of pain.Type: GrantFiled: July 19, 2012Date of Patent: August 16, 2022Assignee: Torrent Pharmaceuticals Ltd.Inventors: Sunil Sadanand Nadkarni, Jaya Abraham, Kapil Khatri, Vipul Mittal
-
Patent number: 11331334Abstract: The present invention relates to an intranasal composition, particularly once weekly intranasal composition comprising methylcobalamin and at least one gelling agent and a process for preparation thereof.Type: GrantFiled: February 5, 2018Date of Patent: May 17, 2022Inventors: Jaya Abraham, Vivek Mishra, Kiran Chaudhari, Vipul Mittal
-
Patent number: 10772879Abstract: This invention relates to pharmaceutical formulations comprising 1-(2-thien-2?-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2?-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof. The formulations of this invention are for treating diseases associated with advanced glycation end products.Type: GrantFiled: April 5, 2016Date of Patent: September 15, 2020Assignee: Torrent Pharmaceuticals LimitedInventors: Chaitanya Dutt, Jaya Abraham, Vivek Mishra, Amit Kesarwani, Ramesh Chandra Gupta, Shailesh Deshpande, Shital Kumar Zambad, Anoop Mathur, Jignesh Kotecha, Sachin Latad, Manish Patel, Anita Chaudhari
-
Patent number: 10717727Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: GrantFiled: February 4, 2019Date of Patent: July 21, 2020Assignee: Torrent Pharmaceuticals LimitedInventors: Chaitanya Dutt, Rameshchandra Gupta, Manish Patel, Jaya Abraham, Vivek Mishra, Amit Kesarwani, Shailesh Deshpande, Shital Kumar Zambad, Anoop Mathur, Jignesh Kotecha, Sachin Latad, Anita Chaudhari
-
Publication number: 20200009179Abstract: The present invention relates to an intranasal composition, particularly once weekly intranasal composition comprising methylcobalamin and at least one gelling agent and a process for preparation thereof.Type: ApplicationFiled: February 5, 2018Publication date: January 9, 2020Inventors: Jaya ABRAHAM, Vivek MISHRA, Kiran CHAUDHARI, Vipul MITTAL
-
Patent number: 10471005Abstract: Present invention relates to a low dose pharmaceutical composition, preferably oral composition comprising therapeutically effective amount of [(2-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H,5H-10-thia-1,4a-diaza-benzo[a]azulene-3-carbonyl)-amino]-acetic acid (compound A) in the range of 2.5 mg to 60 mg. Present invention also relates to a method of treating inflammatory bowel disease in a mammal by administrating said low dose pharmaceutical composition. Further, present invention relates to a use of the compound A for the preparation of low dose pharmaceutical composition for the treatment of inflammatory bowel disease in a mammal.Type: GrantFiled: February 22, 2017Date of Patent: November 12, 2019Assignee: Torrent Pharmaceuticals LimitedInventors: Chaitanya Dutt, Vijay Chauthaiwale, Ram Gupta, Shitalkumar Zambad, Shailesh Deshpande, Jignesh Kotecha, Ramesh Gupta, Sanjay Srivastava, Laxmikant Chhipa, Jaya Abraham
-
Publication number: 20190175491Abstract: The present invention relates to topical pharmaceutical compositions comprising Apremilast in an amount of about 0.1 to 5% w/w of the total composition and one or more pharmaceutically acceptable excipients and process for their preparation. The present invention further relates to method for treatment of skin diseases using topical pharmaceutical compositions comprising Apremilast.Type: ApplicationFiled: June 14, 2017Publication date: June 13, 2019Inventors: Jaya Abraham, Vivek Mishra, Kiran Chaudhari, Vipul Mittal
-
Publication number: 20190169175Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: ApplicationFiled: February 4, 2019Publication date: June 6, 2019Applicant: TORRENT PHARMACEUTICALS LIMITEDInventors: Chaitanya DUTT, Rameshchandra GUPTA, Manish PATEL, Jaya ABRAHAM, Vivek MISHRA, Amit KESARWANI, Shailesh DESHPANDE, Shital Kumar ZAMBAD, Anoop MATHUR, Jignesh KOTECHA, Sachin LATAD, Anita CHAUDHARI
-
Patent number: 10292948Abstract: Disclosed herein are pharmaceutical compositions for nasal administration comprising tapentadol, their preparation and their use in the treatment of pain.Type: GrantFiled: January 10, 2018Date of Patent: May 21, 2019Assignee: Torrent Pharmaceuticals LimitedInventors: Jaya Abraham, Vivek Mishra, Vipul Mittal, Kiran Chaudhari
-
Publication number: 20190127381Abstract: Provided herein are novel fused pyrimidinone derivatives of Formula I and synthetic intermediates that are useful in preparing the compounds of formula (I). Further provided herein is a method for preparation of a compound of formula (I) or intermediates, a pharmaceutical composition comprising a compound of formula (I), and use of a compound of formula (I).Type: ApplicationFiled: April 25, 2017Publication date: May 2, 2019Applicant: TORRENT PHARMACEUTICALS LIMITEDInventors: Chaitanya DUTT, Deepa JOSHI, Milind RODE, Sanjay SRIVASTAVA, Davinder TULI, Ramesh Chandra GUPTA, Deepak RAI, Prashant JAMADARKHANA, Shailesh DESHPANDE, Vivek MISHRA, Jaya ABRAHAM
-
Patent number: 10233175Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: GrantFiled: April 5, 2016Date of Patent: March 19, 2019Assignee: Torrent Pharmaceuticals LimitedInventors: Chaitanya Dutt, Rameshchandra Gupta, Manish Patel, Jaya Abraham, Vivek Mishra, Amit Kesarwani, Shailesh Deshpande, Shital Kumar Zambad, Anoop Mathur, Jignesh Kotecha, Sachin Latad, Anita Chaudhari
-
Patent number: 10206923Abstract: Present invention relates to a stable pharmaceutical composition comprising intimate mixture of alogliptin and metformin, and suitable pharmaceutically acceptable excipient/s; wherein metformin is present in about 3.3 parts or more parts by weight relative to 100 parts by weight of the total weight of part comprising alogliptin. Invention also encompasses various processes of preparing said pharmaceutical composition and its use in improving glycemic control in adults with type 2 diabetes mellitus.Type: GrantFiled: August 17, 2016Date of Patent: February 19, 2019Assignee: Torrent Pharmaceuticals LimitedInventors: Jaya Abraham, Suryakant Navale, Pradip Mukhopadhyay, Muzaffar Madny
-
Publication number: 20180235966Abstract: Present invention relates to a stable pharmaceutical composition comprising intimate mixture of alogliptin and metformin, and suitable pharmaceutically acceptable excipient/s; wherein metformin is present in about 3.3 parts or more parts by weight relative to 100 parts by weight of the total weight of part comprising alogliptin. Invention also encompasses various processes of preparing said pharmaceutical composition and its use in improving glycemic control in adults with type 2 diabetes mellitus.Type: ApplicationFiled: August 17, 2016Publication date: August 23, 2018Applicant: TORRENT PHARMACEUTICALS LIMITEDInventors: Jaya ABRAHAM, Suryakant NAVALE, Pradip MUKHOPADHYAY, Muzaffar MADNY
-
Publication number: 20180193290Abstract: Disclosed herein are pharmaceutical compositions for nasal administration comprising tapentadol, their preparation and their use in the treatment of pain.Type: ApplicationFiled: January 10, 2018Publication date: July 12, 2018Applicant: Torrent Pharmaceuticals LimitedInventors: Jaya ABRAHAM, Vivek MISHRA, Vipul MITTAL, Kiran CHAUDHARI
-
Publication number: 20180118728Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: ApplicationFiled: April 5, 2016Publication date: May 3, 2018Applicant: TORRENT PHARMACEUTICALS LIMITEDInventors: Chaitanya DUTT, Rameshchandra GUPTA, Manish PATEL, Jaya ABRAHAM, Vivek MISHRA, Amit KESARWANI, Shailesh DESHPANDE, Shital Kumar ZAMBAD, Anoop MATHUR, Jignesh KOTECHA, Sachin LATAD, Anita CHAUDHARI
-
Publication number: 20180110763Abstract: This invention relates to pharmaceutical formulations comprising 1-(2-thien-2?-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2?-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof.Type: ApplicationFiled: April 5, 2016Publication date: April 26, 2018Applicant: TORRENT PHARMACEUTICALS LIMITEDInventors: Chaitanya DUTT, Jaya ABRAHAM, Vivek MISHRA, Amit KESARWANI, Ramesh Chandra GUPTA, Shailesh DESHPANDE, Shital Kumar ZAMBAD, Anoop MATHUR, Jignesh KOTECHA, Sachin LATAD, Manish PATEL, Anita CHAUDHARI
-
Publication number: 20170157129Abstract: Present invention relates to a low dose pharmaceutical composition, preferably oral composition comprising therapeutically effective amount of [(2-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H,5H-10-thia-1,4a-diaza-benzo[a]azulene-3-carbonyl)-amino]-acetic acid (compound A) in the range of 2.5 mg to 60 mg. Present invention also relates to a method of treating inflammatory bowel disease in a mammal by administrating said low dose pharmaceutical composition. Further, present invention relates to a use of the compound A for the preparation of low dose pharmaceutical composition for the treatment of inflammatory bowel disease in a mammal.Type: ApplicationFiled: February 22, 2017Publication date: June 8, 2017Applicant: TORRENT PHARMACEUTICALS LIMITEDInventors: Chaitanya DUTT, Vijay CHAUTHAIWALE, Ram GUPTA, Shitalkumar ZAMBAD, Shailesh DESHPANDE, Jignesh KOTECHA, Ramesh GUPTA, Sanjay SRIVASTAVA, Laxmikant CHHIPA, Jaya ABRAHAM
-
Patent number: 9629818Abstract: The present invention relates to a pharmaceutical composition of tapentadol for parenteral administration which provides prolonged release of tapentadol. Present invention also relates to the process of preparation of pharmaceutical composition of tapentadol for parenteral administration and its use in the treatment of pain.Type: GrantFiled: November 1, 2012Date of Patent: April 25, 2017Assignee: TORRENT PHARMACEUTICALS LTD.Inventors: Sunil Sadanand Nadkarni, Jaya Abraham, Kapil Khatri
-
Patent number: 9610247Abstract: Present invention relates to a low dose pharmaceutical composition, preferably oral composition comprising therapeutically effective amount of [(2-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H,5H-10-thia-1,4a-diaza-benzo[a]azulene-3-carbonyl)-amino]-acetic acid (compound A) in the range of 2.5 mg to 60 mg. Present invention also relates to a method of treating inflammatory bowel disease in a mammal by administrating said low dose pharmaceutical composition. Further, present invention relates to a use of the compound A for the preparation of low dose pharmaceutical composition for the treatment of inflammatory bowel disease in a mammal.Type: GrantFiled: May 12, 2014Date of Patent: April 4, 2017Assignee: Torrent Pharmaceuticals LimitedInventors: Chaitanya Dutt, Vijay Chauthaiwale, Ram Gupta, Shitalkumar Zambad, Shailesh Deshpande, Jignesh Kotecha, Ramesh Gupta, Sanjay Srivastava, Laxmikant Chhipa, Jaya Abraham
-
Patent number: 9364518Abstract: The present invention provides a pharmaceutical composition capable of forming in-situ implant comprising goserelin or its pharmaceutically acceptable salts thereof, biodegradable polymer and a biocompatible organic solvent wherein the biocompatible organic solvent is miscible to dispersible in aqueous medium or body fluid. The present invention further provides a process for the preparation of pharmaceutical composition capable of forming in-situ implant. A kit containing composition for in-situ implant is provided comprising a first vial comprising a composition comprising a biodegradable polymer and a biocompatible organic solvent; wherein the biocompatible organic solvent is miscible to dispersible in aqueous medium or body fluid; and a second vial comprising goserelin acetate.Type: GrantFiled: June 24, 2011Date of Patent: June 14, 2016Assignee: Torrent Pharmaceuticals LimitedInventors: Sunil S. Nadkarni, Jaya Abraham, Amit Kesarwani, Astha Parmar